Diabetes POCT - HbA1c Fluorescence Immunoassay Diagnostic Test Kit

Diabetes POCT - HbA1c Fluorescence Immunoassay Diagnostic Test Kit

Tests

Information

Optical Q HbA1c diagnostic test is a proprietary point-of-care (POCT) fluorescence immunoassay (FIA) designed for prompt and accurate in-vitro quantitative measurement of HbA1c. Optical Q HbA1c reagent test is the first HbA1c FIA test kit that does not require processing with a centrifuge, allowing for a) quicker results and b) higher accuracy. TECHNICAL HIGHLIGHTS -- Approved by CE (IVD), Korea MFDS -- Rapid and quantitative immunoassay -- High performance of CV < 10% -- Assay time of 15 minutes -- 25 Tests/Kit
Sub Category Offered
Immunoassay TestsIn Vitro Diagnostic TestsPoint of Care Professional Diagnostics
OptiBio Co., Ltd.Z5.E50OptiBio is a South Korean healthcare company focused on fluorescence immunoassay (FIA) solutions. In 2020, OptiBio was selected by a research fund sponsored by the Bill & Melinda Gates Foundation for its unique and dedicated approach to immunoassay. OptiBio's competitive advantage stems from its strong foundation of experts, each specialized in fields crucial for product development. Our R&D is divided into 3 different teams of scientists and engineers dedicated to the independent development of diagnostic markers, test kits, and analyzers. OptiBio will continue to create, improve, and innovate world-class diagnostic solutions in the field of fluorescence immunoassay and point-of-care testing (POCT). Through this, we aim to ultimately transform medical diagnosis into a universally available right.

Join the event!